Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial. Ma RW, Liu K, Xie J. Lancet 2024;404:433-434.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma RW, Liu K, Xie J. Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial. Lancet 2024;404:433-434.
PMID: 39097392